Gsk Share Discussion Threads

[tradermichael] 28/3/2019 07:38

March 27th, 2019 – A study published in the Pediatric Infectious Disease Society concluded saying, ‘if licensed, the Priorix / MMR-RIT vaccine could provide a valid option for the prevention of measles, mumps, and rubella in children, 12-to 15-months-old in the United States.
Additionally, these researchers said the ‘Priorix / MMR-RIT vaccine would reduce potential risks of a future vaccine shortage'.

This is important news since there have been significant measles and mumps outbreaks in the USA during 2019.
In this new study, the researchers assessed the immunogenicity and safety of the Priorix / MMR-RIT vaccine from GlaxoSmithKline (GSK) was compared with those of the existing measles vaccine market leader, MMR II, which is produced by Merck.

[montyhedge] 27/3/2019 14:36

Looking good guys.

[badtime] 26/3/2019 15:13

Hardly crowing ...and certainly not multiple posting as you were predicting where this share price was/is going ...in the meantime I'm happy to see it where it is ....ttfn

[mattboxy] 25/3/2019 22:41

Perhaps it's worth remembering that at 10-00 the night before brexit vote was confirmed you could get 5-1 on it happeningAlso Donald Trump was 6-1 to beat Hilary the day before The bookies do screw up sometimes!

[zicopele] 25/3/2019 11:39

Not sure why bedtime is crowing.

GSK still going nowhere

[grahamite2] 22/3/2019 09:25

Thanks steeplejack, good thought. The serious money always has a better idea of how things are really going than the newspapers do.

[steeplejack] 22/3/2019 08:44

(Sorry again Spud)


The Betfair odds on a No Deal are 11/4...not very short odds,

[amt] 22/3/2019 07:43

I don't think we need to worry about Brexit. Due to NI situation it's impossible to enact a true Brexit (hence backstop) and leaving without a deal seems unlikely. They will kick the can down the road either through Backstop or a new deal. It will go on for years but trading conditions won't change that much. All very depressing but nobody thought about NI at the time of the vote so nobody realised that unless NI leaves UK or is treated differently proper Brexit as described at the time of the vote cannot happen.

[badtime] 21/3/2019 18:43

Sogoes...him and the other bod Zico something or other......totally silent because they called it wrong

[philanderer] 21/3/2019 17:25

Fine update from DREAMM-1 👍

[sogoesit] 21/3/2019 16:05

If only montyhedge were here to confirm such a recovery we might believe it were true! ;-)

[steeplejack] 21/3/2019 16:03

Sorry Spud.Whole sector is strong.AstraZeneca has hit a years high and Smith&Nephew is only a few coppers shy.Suggests that GSK might have further to run.There's apparent technical resistance at 1568.See if we can get through that barrier.

[spud] 21/3/2019 15:53

Meantime, on the GSK thread (which i believe this is although you could be forgiven for thinking its a BREXIT one) GSK continues to recover.

spud

[steeplejack] 21/3/2019 15:50

Teresa May(or should we call her Thelma)seems quite prepared to drive the UK over the cliff with No Deal unless her flawed plan is voted through.I'm very surprised that the prime ministerial position as an office has such dictatorial power.She's now behaving in a rather feral manner and frankly I'm a little worried about her health.She's certainly earned a holiday.A good long break in Elba or St Helena spring to mind.

[alphorn] 21/3/2019 13:06

FIO. Bad news for patients. A very difficult disease area, but big rewards if someone gets there. This was in Phase III btw.

Biogen shares plunge nearly 30% after ending trial for potential blockbuster Alzheimer's drug Aducanumab.

[grahamite2] 21/3/2019 12:24

Good post sogoesit.

Yes, she probably would have made a first-rate clerk in the DHSS or something.

[sogoesit] 21/3/2019 11:39

Yep, failure to read and understand the opposition's position and their perception of you in a negotiation is an amateur mistake but all too common.
Having your own world-view in mind, and assuming it to be the same as other cultures', is pervasive in us humans and in a lot of commercial negotiations. If you don't understand another's culture better find someone who can or seek help.

May is, imv, a bureacratic servant with historical (her background) "factual" views not suited to imagining the benefits that arise from short term destabilisation that can be used to reset strategy.
Apart from the fact that she appears to be a pathological liar which is not a useful behaviour to have as a negotiator!
(It was always clear that, strategically, the EU would seek to punish an exiting nation if only for its self-protection).

[steeplejack] 20/3/2019 22:05

Oh dear,the French are such a disappointment.They fail to understand the British mentality.Churchill spoke to the Canadian Parliament in 1941 and told them how the French military leaders behaved a year earlier: "When I warned them that Britain would fight on alone, whatever they did, their generals told their Prime Minister and his divided cabinet, "In three weeks England will have her neck wrung like a chicken". Some chicken (huge cheers). Some neck!" (more cheers and applause).I hold May largely responsible for the current impasse but ultimately the blame might well be laid at the EU's door for being intransigent.I voted remain but I increasingly feel we should just leave without a deal.The EU seems to forget that we'll still be the EU's largest trading partner even after we've left.

[alphorn] 20/3/2019 13:09

Moving as a hedge again now as GBP falls. A good share for a GBP based investor to hold.

[badtime] 20/3/2019 13:08

Sp has been pretty stable last few weeks which has quietened a couple of posters

[jadeticl3] 20/3/2019 10:44

TM, thanks for this information. Maybe, just maybe, it is starting to awake this morning!

[tradermichael] 20/3/2019 09:59

I think that GSK is sitting on a goldmine of new immuno-oncology drugs with the acquisition of Tesaro, as the results of clinical trials start to filter through during 2019. GSK recognised this in the massive investment made through the purchase of this asset. The market has yet to wake up to the value of this opportunity.

[tradermichael] 20/3/2019 09:48

For information, there is a former tie-up between Tesaro and a company called AnaptysBio

TESARO Partnership
Under our immuno-oncology collaboration with TESARO, we have granted exclusive rights to TESARO to develop and commercialize the following AnaptysBio-generated antibody product candidates:
Anti-PD-1 Monospecific Antagonist Antibody (Dostarlimab, TSR-042): BLA Filing Anticipated in H2 2019;
Anti-TIM-3 Monospecific Antagonist Antibody (TSR-022): Dose escalation completed in Phase 1, combination trial with TSR-042 has been initiated;
Anti-LAG-3 Monospecific Antagonist Antibody (TSR-033): Phase 1 trial initiated, and
Anti-PD-1/LAG-3 Bispecific Antagonist Antibody (TSR-075): lead candidate identified, IND-enabling studies on-going.